Enzon Pharmaceuticals Inc Stock Nasdaq
Equities
US2939041081
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2022 | 26K 35.53K | Sales 2023 | - | Capitalization | 6.94M 9.49M |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | 1M 1.37M | EV / Sales 2022 | -1,103 x |
Net cash position 2022 | 46.98M 64.2M | Net cash position 2023 | 47.01M 64.24M | EV / Sales 2023 | - |
P/E ratio 2022 |
-12.5
x | P/E ratio 2023 |
70.9
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 89.16% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 80 | 13-12-12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Randolph Read
CHM | Chairman | 71 | 20-08-03 |
Director/Board Member | 67 | 22-06-30 | |
Jordan Bleznick
BRD | Director/Board Member | 68 | 20-08-03 |
1st Jan change | Capi. | |
---|---|---|
-1.65% | 103B | |
+6.75% | 101B | |
+6.49% | 23.07B | |
-12.60% | 22.23B | |
-5.34% | 18.05B | |
-39.98% | 17.18B | |
-10.17% | 16.94B | |
+6.12% | 14.07B | |
+35.47% | 12.35B |